This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...

The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Alkem Laboratories has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc (Sonnet) to develop, manufacture and commercialise the drug candidate SON-080 for the ...

Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...

Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...